Name : Mouse IGFBP-3R Protein
Product Source :
Recombinant Mouse IGFBP-3R Protein is expressed from HEK293 with hFc tag at the C-Terminus. It contains Gly39-Arg204.[Accession | Q9D123-1]
Molecular Weight :
The protein has a predicted MW of 44.4 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Tris-Bis PAGE result.
Endotoxin Level :
Less than 1EU per μg by the LAL method.
Purity :
> 95% as determined by Tris-Bis PAGE> 95% as determined by HPLC
Formulation :
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution :
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage and Stability :
-20 to -80°C for 12 months as supplied from date of receipt.-80°C for 3-6 months after reconstitution.2-8°C for 2-7 days after reconstitution.Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Product Concentration :
Tris-Bis PAGE Mouse IGFBP-3R on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. SEC-HPLC The purity of Mouse IGFBP-3R is greater than 95% as determined by SEC-HPLC.
Background :
Insulin-like growth factor-binding protein-3 (IGFBP-3) is a multifunctional protein known for modulating mitogenic and metabolic actions of IGFs as well as exerting a variety of biological actions not involving IGF. IGFBP-3 inhibits airway inflammation and hyper-responsiveness via an IGF-independent mechanism that involves activation of IGFBP-3R signaling and cross-talk with NF-κB signaling. The IGFBP-3/IGFBP-3R system therefore plays a pivotal role in the pathogenesis of asthma and can serve as a newly identified potential therapeutic target for this debilitating disease.
Synonyms :
IGFBP-3R; GFBP3R; LOC124446; TMEM219
References & Citations :
(1) Lee YC, Jogie-Brahim S, Lee DY, Han J, Harada A, Murphy LJ, Oh Y. Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem. 2011 May 20;286(20):17898-909. doi: 10.1074/jbc.M111.231035. Epub 2011 Mar 7. PMID: 21383009; PMCID: PMC3093865.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
ASAM/CLMP Protein
IL-17RC Protein
Popular categories:
FGF-11
Protease Inhibitors